Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT), 36549-36550 [2021-14686]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
Item No.
Bureau
Subject
4 ......................
INTERNATIONAL .....................................
5 ......................
ENFORCEMENT ......................................
6 ......................
WIRELESS TELE-COMMUNICATIONS ..
TITLE: Mandatory Electronic Filing of Section 325(c) Applications, International
Broadcast Applications, and Dominant Carrier Section 63.10(c) Quarterly Reports (IB Docket No. 21–265).
SUMMARY: The Commission will consider an Order that would amend rules to require the remaining applications and reports to be filed electronically in the International Bureau Filing System (IBFS) and eliminate duplicative paper filing requirements.
TITLE: Enforcement Bureau Action.
SUMMARY: The Commission will consider an enforcement action.
TITLE: Promoting Technological Solutions to Combat Contraband Wireless Device
Use in Correctional Facilities (GN Docket No. 13–111).
SUMMARY: The Commission will consider a Second Report and Order taking
steps to combat contraband wireless devices in correctional facilities and Second Further Notice of Proposed Rulemaking seeking comment on additional
technological solutions to combat contraband device usage in correctional facilities.
*
*
*
*
The meeting will be webcast with
open captioning at: www.fcc.gov/live.
Open captioning will be provided as
well as a text only version on the FCC
website. Other reasonable
accommodations for people with
disabilities are available upon request.
In your request, include a description of
the accommodation you will need and
a way we can contact you if we need
more information. Last minute requests
will be accepted but may be impossible
to fill. Send an email to: fcc504@fcc.gov
or call the Consumer & Governmental
Affairs Bureau at 202–418–0530.
Additional information concerning
this meeting may be obtained from the
Office of Media Relations, (202) 418–
0500. Audio/Video coverage of the
meeting will be broadcast live with
open captioning over the internet from
the FCC Live web page at www.fcc.gov/
live.
Draft Advisory Opinion 2021–06:
Representative Robin Kelly and the
Democratic Party of Illinois
Draft Advisory Opinion 2021–07: PAC
Management Services LLC
(‘‘PACMS’’)
Management and Administrative
Matters
Federal Communications Commission.
Marlene Dortch,
Secretary.
Centers for Disease Control and
Prevention
*
BILLING CODE 6712–01–P
FEDERAL ELECTION COMMISSION
Authority: Government in the Sunshine
Act, 5 U.S.C. 552b.
Laura E. Sinram,
Acting Secretary and Clerk of the
Commission.
[FR Doc. 2021–14899 Filed 7–8–21; 4:15 pm]
BILLING CODE 6715–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment (CHACHSPT). The
CHACHSPT consists of 18 experts in
fields associated with public health;
epidemiology; laboratory practice;
immunology; infectious diseases; drug
abuse; behavioral science; health
education; healthcare delivery; state
health programs; clinical care;
preventive health; medical education;
health services and clinical research;
SUMMARY:
Thursday, July 15, 2021
at 10:00 a.m.
PLACE: Virtual meeting. Note: because
of the covid-19 pandemic, we will
conduct the open meeting virtually. If
you would like to access the meeting,
see the instructions below.
STATUS: This meeting will be open to
the public. To access the virtual
meeting, go to the commission’s website
www.fec.gov and click on the banner to
be taken to the meeting page.
MATTERS TO BE CONSIDERED:
TIME AND DATE:
17:26 Jul 09, 2021
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
ACTION:
Sunshine Act Meeting
VerDate Sep<11>2014
CONTACT PERSON FOR MORE INFORMATION:
Solicitation of Nominations for
Appointment to the CDC/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment (CHACHSPT)
[FR Doc. 2021–14723 Filed 7–9–21; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
36549
Jkt 253001
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
and healthcare financing, who are
selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS).
DATES: Nominations for membership on
the CHACHSPT must be received no
later than August 31, 2021. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
electronically mailed to nchhstppolicy@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Staci Morris, M.S., Committee
Management Specialist, National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention, CDC, Atlanta, Georgia
30329–4027; Telephone: (404) 718–
7479; nchhstppolicy@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Secretary of HHS, and by delegation, the
CDC Director and the HRSA
Administrator, are authorized by the
PHS Act to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies related to the cases, diagnosis,
treatment, control, and prevention of
physical and mental diseases, and other
impairments; (2) assist states and their
political subdivisions in preventing,
suppressing, and treating communicable
diseases and other preventable
conditions and in promoting health and
well-being; (3) assist public and nonprofit private entities in preventing,
controlling and treating sexually
transmitted diseases (STDs), including
the Human Immunodeficiency Virus
(HIV); (4) improve health and achieve
health equity through access to quality
services and a skilled health workforce
and innovative programs; (5) support
healthcare services to persons living
with or at risk for HIV, viral hepatitis,
E:\FR\FM\12JYN1.SGM
12JYN1
khammond on DSKJM1Z7X2PROD with NOTICES
36550
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
and other STDs; and (6) advance the
education of health professionals and
the public from HIV, viral hepatitis, and
other STDs.
The CDC/HRSA Advisory Committee
on HIV and STD Prevention and
Treatment meets at least two times each
calendar year, or at the discretion of the
Designated Federal Officer in
consultation with the CHACHSPT cochairs.
The CDC/HRSA Advisory Committee
on HIV and STD Prevention and
Treatment shall advise the Director,
CDC, and the Administrator, HRSA,
regarding objectives, strategies, policies,
and priorities for HIV, viral hepatitis,
and other STD prevention and treatment
efforts, including surveillance of HIV
infection, Acquired Immunodeficiency
Syndrome (AIDS), viral hepatitis, other
STDs, and related behaviors;
epidemiologic, behavioral, health
services, and laboratory research on
HIV, viral hepatitis, and other STDs;
identification of policy issues related to
HIV/viral hepatitis/STD professional
education, patient healthcare delivery,
and prevention services; agency policies
about prevention of HIV, viral hepatitis
and other STDs, treatment, healthcare
delivery, and research and training;
strategic issues influencing the ability of
CDC and HRSA to fulfill their missions
of providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
agencies in their development of
responses to emerging health needs
related to HIV, viral hepatitis and other
STDs.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of public
health; epidemiology; laboratory
practice; immunology; infectious
diseases; drug abuse; behavioral science;
health education; healthcare delivery;
state health programs; clinical care;
preventive health; medical education;
health services and clinical research;
and healthcare financing. The
Committee shall also include
representation of persons with HIV and
other affected populations; state and
local health and education agencies;
HIV/viral hepatitis/STD communitybased organizations; and the ethics or
faith-based community. Federal
employees will not be considered for
membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of CHACHSPT
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
objectives. The U.S. Department of
Health and Human Services policy
stipulates that committee membership
be balanced in terms of points of view
represented, and the committee’s
function. Appointments shall be made
without discrimination on the basis of
age, race, ethnicity, gender, sexual
orientation, gender identity, HIV status,
disability, and cultural, religious, or
socioeconomic status. Nominees must
be U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. Committee members are
Special Government Employees (SGEs),
requiring the filing of financial
disclosure reports at the beginning and
annually during their terms. Individuals
who are selected for appointment will
be required to provide detailed
information regarding their financial
interests and, for example, any work
they do for the federal government
through research grants or contracts.
Disclosure of this information is
required in order for CDC ethics officials
to determine whether there is a conflict
between the SGE’s public duties as
members of CHACHSPT and their
private interests, including an
appearance of a loss of impartiality as
defined by federal laws and regulations,
and to identify any required remedial
action needed to address the potential
conflict. CDC reviews potential
candidates for CHACHSPT membership
when a vacancy arises and provides a
slate of nominees for consideration to
the Secretary of HHS for final selection.
HHS notifies selected candidates of
their appointment near the start of the
term in December 1, 2021, or as soon as
the HHS selection process has been
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
for an open position may be
reconsidered for a subsequent open
position. SGE nominees must be U.S.
citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
D Current curriculum vitae or resume,
including complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
(Candidates may submit letters(s)
from current HHS employees if they
wish, but at least one letter must be
submitted by a person not employed by
an HHS agency (e.g., CDC, NIH, FDA,
etc.).
D A biographical sketch of the
nominee (500 words or fewer).
D A letter of interest or personal
statement from the nominee stating how
their expertise would inform the work
of CHACHSPT.
Nominations may be submitted
directly by the individual seeking
nomination or by the person/
organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–14686 Filed 7–9–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–21GH; Docket No. CDC–2021–
0065]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Using Real-time Prescription and
Insurance Claims Data to Support the
HIV Care Continuum. This proposed
collection will collect data to evaluate
SUMMARY:
E:\FR\FM\12JYN1.SGM
12JYN1
]]>Agencies
[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Pages 36549-36550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14686]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the CDC/HRSA
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and
Treatment (CHACHSPT)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the CDC/HRSA Advisory Committee
on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT).
The CHACHSPT consists of 18 experts in fields associated with public
health; epidemiology; laboratory practice; immunology; infectious
diseases; drug abuse; behavioral science; health education; healthcare
delivery; state health programs; clinical care; preventive health;
medical education; health services and clinical research; and
healthcare financing, who are selected by the Secretary of the U.S.
Department of Health and Human Services (HHS).
DATES: Nominations for membership on the CHACHSPT must be received no
later than August 31, 2021. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be electronically mailed to
[email protected].
FOR FURTHER INFORMATION CONTACT: Staci Morris, M.S., Committee
Management Specialist, National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, Atlanta, Georgia 30329-4027; Telephone:
(404) 718-7479; [email protected].
SUPPLEMENTARY INFORMATION: The Secretary of HHS, and by delegation, the
CDC Director and the HRSA Administrator, are authorized by the PHS Act
to: (1) Conduct, encourage, cooperate with, and assist other
appropriate public health authorities, scientific institutions, and
scientists in the conduct of research, investigations, experiments,
demonstrations, and studies related to the cases, diagnosis, treatment,
control, and prevention of physical and mental diseases, and other
impairments; (2) assist states and their political subdivisions in
preventing, suppressing, and treating communicable diseases and other
preventable conditions and in promoting health and well-being; (3)
assist public and non-profit private entities in preventing,
controlling and treating sexually transmitted diseases (STDs),
including the Human Immunodeficiency Virus (HIV); (4) improve health
and achieve health equity through access to quality services and a
skilled health workforce and innovative programs; (5) support
healthcare services to persons living with or at risk for HIV, viral
hepatitis,
[[Page 36550]]
and other STDs; and (6) advance the education of health professionals
and the public from HIV, viral hepatitis, and other STDs.
The CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment meets at least two times each calendar year, or at the
discretion of the Designated Federal Officer in consultation with the
CHACHSPT co-chairs.
The CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment shall advise the Director, CDC, and the Administrator, HRSA,
regarding objectives, strategies, policies, and priorities for HIV,
viral hepatitis, and other STD prevention and treatment efforts,
including surveillance of HIV infection, Acquired Immunodeficiency
Syndrome (AIDS), viral hepatitis, other STDs, and related behaviors;
epidemiologic, behavioral, health services, and laboratory research on
HIV, viral hepatitis, and other STDs; identification of policy issues
related to HIV/viral hepatitis/STD professional education, patient
healthcare delivery, and prevention services; agency policies about
prevention of HIV, viral hepatitis and other STDs, treatment,
healthcare delivery, and research and training; strategic issues
influencing the ability of CDC and HRSA to fulfill their missions of
providing prevention and treatment services; programmatic efforts to
prevent and treat HIV, viral hepatitis, and other STDs; and support to
the agencies in their development of responses to emerging health needs
related to HIV, viral hepatitis and other STDs.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. Nominees will be selected based on expertise in
the fields of public health; epidemiology; laboratory practice;
immunology; infectious diseases; drug abuse; behavioral science; health
education; healthcare delivery; state health programs; clinical care;
preventive health; medical education; health services and clinical
research; and healthcare financing. The Committee shall also include
representation of persons with HIV and other affected populations;
state and local health and education agencies; HIV/viral hepatitis/STD
community-based organizations; and the ethics or faith-based community.
Federal employees will not be considered for membership. Members may be
invited to serve for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of CHACHSPT objectives. The U.S.
Department of Health and Human Services policy stipulates that
committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees (SGEs), requiring the filing
of financial disclosure reports at the beginning and annually during
their terms. Individuals who are selected for appointment will be
required to provide detailed information regarding their financial
interests and, for example, any work they do for the federal government
through research grants or contracts. Disclosure of this information is
required in order for CDC ethics officials to determine whether there
is a conflict between the SGE's public duties as members of CHACHSPT
and their private interests, including an appearance of a loss of
impartiality as defined by federal laws and regulations, and to
identify any required remedial action needed to address the potential
conflict. CDC reviews potential candidates for CHACHSPT membership when
a vacancy arises and provides a slate of nominees for consideration to
the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in December
1, 2021, or as soon as the HHS selection process has been completed.
Note that the need for different expertise varies from year to year and
a candidate who is not selected for an open position may be
reconsidered for a subsequent open position. SGE nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Candidates should submit the following items:
[ssquf] Current curriculum vitae or resume, including complete
contact information (telephone numbers, mailing address, email
address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letters(s) from current HHS employees if
they wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
[ssquf] A biographical sketch of the nominee (500 words or fewer).
[ssquf] A letter of interest or personal statement from the nominee
stating how their expertise would inform the work of CHACHSPT.
Nominations may be submitted directly by the individual seeking
nomination or by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14686 Filed 7-9-21; 8:45 am]
BILLING CODE 4163-18-P
